Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study
Clinical and Molecular Hepatology · 01.07.2024 · 30 (3) · 487-499
DOI: 10.3350/cmh.2024.0145 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.07.2024. Verfasst von Seogsong Jeong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Science and ICT, Institute for Information & Communications Technology Planning & Evaluation, National Research Foundation of Korea.
Abstract (Originalsprache)
Background/Aims: To determine the association between evolutionary changes in metabolic dysfunction-associated steatotic liver disease (MASLD) status and the risk of hepatocellular carcinoma (HCC) in a nationwide population-based cohort.
Methods
Information on study participants was derived from the Korea National Health Insurance Service database. The study population consisted of 5,080,410 participants who underwent two consecutive biennial health screenings between 2009 and 2012. All participants were followed up until HCC, death, or 31 December 2020. The association of evolutionary changes in MASLD status, as assessed by the fatty liver index and cardiometabolic risk factors, including persistent non-MASLD, resolved MASLD, incident MASLD, and persistent MASLD, with HCC risk was evaluated using multivariable-adjusted Cox proportional hazards regression.
Results
Among the 5,080,410 participants with 39,910,331 person-years of follow-up, 4,801 participants developed HCC. The incidence of HCC in participants with resolved, incident, and persistent MASLD was approximately 2.2-, 2.3-, and 4.7-fold higher, respectively, than that in those with persistent non-MASLD among the Korean adult population. When stratifying the participants according to the evolutionary change in MASLD status, persistent (adjusted hazard ratio [aHR], 2.94; 95% confidence interval [CI], 2.68–3.21; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
- Department of Family Medicine, College of Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Family Medicine, Life Clinic, Seoul, Korea.
Förderung
- Ministry of Science and ICT
- Institute for Information & Communications Technology Planning & Evaluation
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Korea National Institute of Health
- Seoul National University Hospital
Zitieren
APA
Jeong, S., Oh, Y. H., Ahn, J. C., Choi, S., Park, S. J., Kim, H. J., Lee, G., Son, J. S., Jang, H., Lee, D. H., Sha, M., Chen, L., Kim, W., & Park, S. M. (2024). Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study. Clinical and Molecular Hepatology, 30(3), 487-499. https://doi.org/10.3350/cmh.2024.0145
Vancouver
Jeong S, Oh YH, Ahn JC, Choi S, Park SJ, Kim HJ, et al. Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study. Clinical and Molecular Hepatology. 2024;30(3):487-499. doi:10.3350/cmh.2024.0145
BibTeX
@article{Jeong2024,
author = {Jeong, Seogsong and Oh, Yun Hwan and Ahn, Joseph C and Choi, Seulggie and Park, Sun Jae and Kim, Hye Jun and Lee, Gyeongsil and Son, Joung Sik and Jang, Heejoon and Lee, Dong Hyeon and Sha, Meng and Chen, Lei and Kim, Won and Park, Sang Min},
title = {Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study},
journal = {Clinical and Molecular Hepatology},
year = {2024},
volume = {30},
number = {3},
pages = {487--499},
doi = {10.3350/cmh.2024.0145}
}
EUVIMED